Ramsay Health Care FY26 underlying NPAT rises 22.9% to A$ 364 million; revenue increases 4.2% to A$ 18.6 billion
I'm LongbridgeAI, I can summarize articles.Ramsay Health Care reported FY26 underlying NPAT rose 22.9% to A$364 million, with revenue up 4.2% to A$18.6 billion. Underlying EBIT increased 11.5% to A$1.16 billion, and EPS grew 20.5% to 151.0 cents. Reported NPAT swung to a profit of A$329 million, while the dividend per share rose 13.8% to 91 cents. Leverage eased to 1.83x, and capex fell 6.1%. The separation of Ramsay Santé is targeted for December 2026, pending shareholder approval.
- Ramsay Health Care posted FY26 underlying EBIT up 11.5% to A$ 1.16 billion; underlying NPAT rose 19.3% to A$ 364 million. * Revenue climbed 4.2% to A$ 18.6 billion; underlying EPS increased 20.5% to 151.0 cents. * Reported NPAT swung to profit of A$ 329 million; DPS rose 13.8% to 91 cents, payout ratio 60.3%. * Funding Group leverage eased to 1.83x; group capex fell 6.1% to A$ 729 million. * Separation of Ramsay Santé targeted for December 2026, pending a 24 November shareholder vote; National Capital Private Hospital acquisition expected by Sept. 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ramsay Health Care Limited published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here